Rakovina Therapeutics Inc.
RKV.V
TSX
| 03/31/2026 | 09/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 20.68% | -67.36% | -249.17% | -249.17% | -172.16% |
| Total Depreciation and Amortization | 4.89% | -1.01% | -1.13% | -1.13% | -7.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 40.72% | 1,161.42% | -33.88% | -33.88% | 320.85% |
| Change in Net Operating Assets | -9.46% | 113.30% | -257.76% | -257.76% | 75.14% |
| Cash from Operations | 40.53% | 26.59% | -581.05% | -581.05% | -348.44% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 114.32% | 114.32% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 75.00% | -220.22% | -220.22% | -- |
| Cash from Financing | -- | -109.47% | 190.01% | 190.01% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 123.96% | 7.17% | 47.80% | 47.80% | -348.44% |